BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and anti-HIV integrase evaluation of 4-oxo-4H-quinolizine-3-carboxylic acid derivatives. 2009

Yi-Sheng Xu, and Cheng-Chu Zeng, and Zi-Guo Jiao, and Li-Ming Hu, and Ru-gang Zhong
Beijing University of Technology, P. R. China. xuys@craes.org.cn

4-Oxo-4H-quinolizine-3-carboxylic acid derivatives bearing sulfamido, carboxylamido, benzimidazole and benzothiazole substituents have been designed and synthesized. The structures of these new compounds were confirmed by (1)H-NMR, (13)C- NMR, IR and ESI (or HRMS) spectra. Compounds were screened for possible HIV integrase inhibitory activity.

UI MeSH Term Description Entries
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D011807 Quinolizines
D002264 Carboxylic Acids Organic compounds containing the carboxy group (-COOH). This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic. Carboxylic Acid,Acid, Carboxylic,Acids, Carboxylic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D019427 HIV Integrase Enzyme of the HUMAN IMMUNODEFICIENCY VIRUS that is required to integrate viral DNA into cellular DNA in the nucleus of a host cell. HIV integrase is a DNA nucleotidyltransferase encoded by the pol gene. HIV Integration Protein,p31 Integrase Protein, HIV,p31 Integrase Protein, Human Immunodeficiency Virus,p31 pol Gene Product, HIV,p31 pol Gene Product, Human Immunodeficiency Virus,Integrase, HIV,Integration Protein, HIV
D019428 HIV Integrase Inhibitors Inhibitors of HIV INTEGRASE, an enzyme required for integration of viral DNA into cellular DNA. Integrase Inhibitors, HIV,Inhibitors, HIV Integrase
D019906 Nuclear Magnetic Resonance, Biomolecular NMR spectroscopy on small- to medium-size biological macromolecules. This is often used for structural investigation of proteins and nucleic acids, and often involves more than one isotope. Biomolecular Nuclear Magnetic Resonance,Heteronuclear Nuclear Magnetic Resonance,NMR Spectroscopy, Protein,NMR, Biomolecular,NMR, Heteronuclear,NMR, Multinuclear,Nuclear Magnetic Resonance, Heteronuclear,Protein NMR Spectroscopy,Biomolecular NMR,Heteronuclear NMR,Multinuclear NMR,NMR Spectroscopies, Protein,Protein NMR Spectroscopies,Spectroscopies, Protein NMR,Spectroscopy, Protein NMR

Related Publications

Yi-Sheng Xu, and Cheng-Chu Zeng, and Zi-Guo Jiao, and Li-Ming Hu, and Ru-gang Zhong
4-oxo-4H-quinolizine-3-carboxylic acids as Mg2+ selective, fluorescent indicators.
January 2001, Bioconjugate chemistry,
Yi-Sheng Xu, and Cheng-Chu Zeng, and Zi-Guo Jiao, and Li-Ming Hu, and Ru-gang Zhong
Design, practical synthesis, and biological evaluation of novel 6-(pyrazolylmethyl)-4-quinoline-3-carboxylic acid derivatives as HIV-1 integrase inhibitors.
September 2012, Molecules (Basel, Switzerland),
Yi-Sheng Xu, and Cheng-Chu Zeng, and Zi-Guo Jiao, and Li-Ming Hu, and Ru-gang Zhong
[Synthesis of some 4-oxo-3,4-dihydroquinazoline-3-carboxylic acid derivatives].
May 1978, Die Pharmazie,
Yi-Sheng Xu, and Cheng-Chu Zeng, and Zi-Guo Jiao, and Li-Ming Hu, and Ru-gang Zhong
3-Methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylic acid.
April 2008, Acta crystallographica. Section E, Structure reports online,
Yi-Sheng Xu, and Cheng-Chu Zeng, and Zi-Guo Jiao, and Li-Ming Hu, and Ru-gang Zhong
Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as novel HIV-1 integrase strand transfer inhibitors.
March 2024, RSC advances,
Yi-Sheng Xu, and Cheng-Chu Zeng, and Zi-Guo Jiao, and Li-Ming Hu, and Ru-gang Zhong
Synthesis and pharmacological evaluation of some 4-oxo-quinoline-2-carboxylic acid derivatives as anti-inflammatory and analgesic agents.
October 2010, Archiv der Pharmazie,
Yi-Sheng Xu, and Cheng-Chu Zeng, and Zi-Guo Jiao, and Li-Ming Hu, and Ru-gang Zhong
Synthesis and antibacterial activity of novel 7-substituted-6-fluoro-1- fluoromethyl-4-oxo-4H-[1,3thiazeto[3,2-a]quinoline-3-carboxylic acid derivatives.
December 1999, Chemical & pharmaceutical bulletin,
Yi-Sheng Xu, and Cheng-Chu Zeng, and Zi-Guo Jiao, and Li-Ming Hu, and Ru-gang Zhong
Studies on antianaphylactic agents. II. Oxidation and reduction of 4-Oxo-4H-1-benzopyran-3-carboxaldehydes. Synthesis of 4-Oxo-4H-1-benzopyran-3-carboxylic acids and 3-hydroxymethylchromones.
December 1974, Chemical & pharmaceutical bulletin,
Yi-Sheng Xu, and Cheng-Chu Zeng, and Zi-Guo Jiao, and Li-Ming Hu, and Ru-gang Zhong
[Reaction of 3-cyano-4H-quinolizine-4-ones].
February 1970, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Yi-Sheng Xu, and Cheng-Chu Zeng, and Zi-Guo Jiao, and Li-Ming Hu, and Ru-gang Zhong
Antiasthma agents. 1. 4-Oxo-4H-(1) benzothieno-(3,2-b)pyran-2-carboxylic acid and 4-oxo-4H-(1)benzofuro(3,2-b)pyran-2-carboxylic acid.
July 1973, Journal of medicinal chemistry,
Copied contents to your clipboard!